Antigenic substance inductor, vaccine precursor, vaccine, antibody, neutralizing antibody, antitoxin, idiotype antibody and/or anti-idiotype antibody which is induced by its idiotype antibody
a technology of antigen-containing substances and antibodies, which is applied in the field of antigen-containing substances, vaccine precursors, antibodies, neutralizing antibodies, idiotype antibodies and/or anti-idiotype antibodies, which can solve the problem of quantitative thermodynamic disruption
Inactive Publication Date: 2002-01-24
KOYAMA SHOZO +1
View PDF0 Cites 3 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
0094] FIG. 9 is a graph of immuno-electrophoresis which demonstrates to induce a new production of antibody in rabbit serum against Pseudomonas aureginosa as an example of effect of the following substances: vaccine precursor, vaccine, antibody, neutralizing antibody, antitoxin and idiotype antibody of which is produced by use of antigenic substance inductor in this invention: and anti-idiotype antibody which is produced by its idiotype antibody.
0095] FIG. 10 is a graph of immuno-electrophoresis which demonstrates to induce a new production of antibody in rabbit serum against Mycobacterium rapid grower as an example of effect of the following substances: vaccine precursor, vaccine, antibody, neutralizing antibody, antitoxin and idiotype antibody of which is produced by use of antigenic substance inductor in this invention: and anti-idiotype antibody which is produced by its idiotype antibody.
Problems solved by technology
This mechanism of fragmentation results from a quantum thermodynamic disruptive and fragmented effects of antigenic substance inductors.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment Construction
[0099] Murine leukemic cells L-1210 (Cancer research institute, Tokyo) was incubated with 2 ml of culture medium (Minimum Essential Medium, Gibco Co.) including bovine fetus serum (Dai-Nipon Pharmace. Co.) at a temperature of 37.degree. C. and 5% CO.sub.2 for 30 hours in the incubator. When a number of cells becomes to around 1.times.10.sup.6 / ml, cell death is induced by an addition of 4 .mu.l of 2M Yoshixol in ethanol. As a result, a determination of cell viability due to an uptake of methylene blue showed a survival cell of 5.times.10.sup.4 at 2 hours after Yoshixol, closely zero level after 20 hours and zero after 30 hours. After confirming extinction of cells in culture medium, the culture medium of which contains extincted cells was centrifuged at 3,000 cycles / min for 5 minutes so that it's supernant was removed. After adding physiological saline of 0.9 cc into the sedimented component and stirring, a centrifuging separation was performed at 1,000 cycles / min for 5 minutes. This...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more PUM
| Property | Measurement | Unit |
|---|---|---|
| diameter | aaaaa | aaaaa |
| temperature | aaaaa | aaaaa |
| pH | aaaaa | aaaaa |
Login to view more
Abstract
This invention provides antigen substance inductors which produce highly selective and/or specific vaccine precursor, vaccine, antibody (including idiotype antibody), neutralizing antibody, antitoxin. This invention is to produce and/or manufacture highly selective and/or specific vaccine precursor, vaccine, antibody (including idiotype antibody), neutralizing antibody, antitoxin by quantum thermodynamic and chemical control of molecular functions and morphogenesis, inducing non-functional complex macromolecules which form organism and/or non-organism and which become to be substance with fundamental structure more closed to an induction of the functions, utilizing the fundamental structure of molecule which is indicated in Formula 3-a as a representative molecule. Moreover, by those produced substances, this invention is to produce and/or manufacture antimicrobial agent, antiviral agent, neutralizing antibody, antitoxin, antitumor agent, anti-protozoa agent (malaria, spirochaeta et. al), molecular discriminating agent, antibody as labeled compounds, histocompatible accelerator on tissues or organs, immuno-response accelerator or immuno-response controller, complement chain reaction accelerator.
Description
[0001] This invention concerns vaccine precursor, vaccine, antibody, neutralizing antibody, antitoxin or idiotype antibody of which is able to discriminate substrates (lipid, carbohydrate, amino acid and so on) of less than molecular weight of 10,000. Such substrates consist of fundamentally morphological structure and / or physiological function and those form complex macromolecules of which are induced species-specific morphological and functional diversity. Either vaccine precursor, vaccine, antibody, neutralizing antibody, antitoxin or idiotype antibody is constituted by macromolecules substance more than one macromolecule. Also, this invention concerns vaccine precursor, vaccine, antibody, neutralizing antibody, antitoxin or the idiotype antibody induced by its idiotype antibody of which was mentioned above. In addition, this invention concerns anti-microbial agent, antiviral agent, anti-tumor agent, anti-protozoa agent (malaria, spirochaeta et. al), antitoxin, antibody of non-bi...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Application Information
Patent Timeline
Login to view more Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/122A61K39/385
CPCA61K31/122Y10T436/200833A61K2039/6012A61K39/385Y02A50/30
Inventor KOYAMA, SHOZOTANAKA, SATOSHI
Owner KOYAMA SHOZO
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap